1.Urotensin Ⅱ levels of the plasma in obstructive sleep apnea syndrome patients and the pathological significance.
Yong LI ; Wen XU ; Lufei BIAN
Chinese Journal of Practical Internal Medicine 2001;0(05):-
Objective To study the levels of Urotensin Ⅱ(UⅡ)in the different grades of obstructive sleep apnea syndrome(OSAHS)patients and the correlation of UⅡ to OSAHS.Methods Seventy-five OSAHS patients were divided into five groups according to light,medium,serious AHI,simple snorers and normal part;UⅡ levels of the plasma were measured and correlation analysed.Results UⅡ levels:light group(10.44?4.12)ng/L、medium group(38.55?15.8)ng/L、serious group(94.78?19.63)ng/L、simple snorers group(1.37?0.42)ng/L、normal group(1.14?0.65)ng/L.Statistic difference existed among these groups(P
7.Comparison between overthick and overthin X ray film
Liu-Zhen BIAN ; Ting-Guo WEN ;
Chinese Medical Equipment Journal 1993;0(05):-
Many factors can result in X ray film overthick and overthin in medical X-ray radiation.In order to ensure the correctness of diagnosis and the focus can be presented at the proper time,it is very im- portant for the overthick and overthin film to be processed and corrected.It has been proved through the test that the satisfied result can be reached through the proper regulating measure such as making a copy of a film.
8.Recent Progress in Research on Small Molecule Agonist of Neurotrophic Factor Receptor Trk
Lei-Si BIAN ; Zhen-Guo LIU ; Wen-An WANG ;
International Journal of Cerebrovascular Diseases 2006;0(11):-
Neurotrophic factor activates signal pathways of intracellular phosphoinositide 3-kinase and extracellular signal-regulated kinase after acting on Trk receptor tyrosine kinase.It promotes the survival and differentiation of neurons.The development of small molecule Trk agonists of non-peptides and neurotrophic factor simulants can avoid a number of shortcomings of neurotrophic factors while agitating trk receptor signal transduction.It may provide a novel therapeutic approach for the treatment of nervous system diseases.
9.Efficacy and Safety of Different Doses of Tirofiban Combined with Coronary Artery Intervention in Treatment of Non ST-segment Elevation Acute Coronary Syndromes
Huan LI ; Fengjun JIAO ; Wen WANG ; Feng BAI ; Nina BIAN
Progress in Modern Biomedicine 2017;17(22):4342-4345
Objective:To investigate the efficacy and safety of different doses of tirofiban combined with coronary artery intervention in treatment of Non ST-segment elevation acute coronary syndromes (NST-ASC).Methods:110 cases with NST-ACS from October 2014 to January 2016 in our hospital were chosen and divided into the all dose group and half dose group.The TIMI blood grade before and after treatment,cardiac function before and after treatment for 30 d,major adverse cardiac events and bleeding events,hospitalization expenses and hospitalization days were recorded and compared between two groups.Results:Compared with before treatment,the TIMI 2 grade and 3 grade were obvious decreased,and the left ventricular end diastolic volume (LVEDV),left ventricular end systolic volume (LVESV) after treatment for 30 d were all obvious decreased,while the left ventricular ejection fraction (LVEF) were significant increased,P<0.05.And the TIMI blood flow grading,LVEDV,LVESV and LVEF before and after treatment in two groups had no significant difference (P>0.05),and the major adverse cardiac events and hospitalization days of two groups had no significant difference,P>0.05.While the bleeding events and hospitalization expense of all dose group was obvious higher than those of half dose group,P<0.05.Conclusions:The half dose group of tirofiban combined with coronary artery intervention in treatment NST-ACS has obvious efficacy,it can decrease the bleeding events and hospitalization expense.
10.Controlled hypotension with remifentanil and propofol in children during endoscopic sinus surgery
Meijie SUN ; Wen BIAN ; Gang LI ; Yuju ZHANG ; Guanggang SHI
Chinese Journal of Postgraduates of Medicine 2011;34(3):1-3
Objective To observe the effect of remifentanil combined with propofol to induce and sustain controlled hypotension in children during endoscopic sinus surgery(ESS). Methods Forty ASA Ⅰ children undergoing adenoidectomy in ESS were divided into control group and controlled hypotension group by random digits table with 20 cases in each group. No controlled hypotension in control group. Anesthesia was induced with propofol,remifentanil and atracurium, and maintained with continuous infusion of propofol 2 min until the target mean arterial pressure (MAP)(55 - 60 mm Hg, 1 mm Hg = 0.133 kPa) was reached,and MAP was maintained at this level during operation in controlled hypotension group. During 15 min before surgical procedure pharynx nasalis blood flow was measured and recorded with laser Dopper flowmetry continuously. The quality of the surgical field in term of blood loss and dryness was established at 15 min after operation starting. Results Controlled hypotension was induced within (2.5 ± 0.3 ) min, the infusion rate ofMAP and heart rate at 15 min after controlled hypotension and 15 min after operation starting were significantly lower than those at controlled hypotension instantly in controlled hypotension group and control group (P < 0.05 ). The pharynx nasalis blood flow decreased at 15 min after controlled hypotension from baseline [(68.3 ± 8.3 )% vs. (99.8 ± 7.9 )%] (P < 0.05 ). The operation time and the quality of the surgical field in term of blood loss and dryness in controlled hypotension group were better than those in control group [(21 ± 4) min vs. (32 ± 6) min and ( 1.8 ± 0.1 ) scores vs. (3.5 ± 0.5) scores] (P < 0.05 ). The awakeextubate time was within 10 min in two groups, and there were no anesthesia related complications.Conclusion Remifentanil combined with propefol can induce and sustain controlled hypotension,reduce pharynx nasal is blood flow and provide good surgical conditions in children for ESS.